News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
482,409 Results
Type
Article (33326)
Company Profile (63)
Press Release (449016)
Multimedia
Podcasts (75)
Webinars (10)
Section
Business (132797)
Career Advice (2519)
Deals (26599)
Drug Delivery (90)
Drug Development (63297)
Employer Resources (143)
FDA (11552)
Job Trends (10821)
News (237145)
Policy (23087)
Tag
Academia (1914)
Academic (1)
Accelerated approval (13)
Adcomms (20)
Allergies (87)
Alliances (33804)
ALS (105)
Alzheimer's disease (1326)
Antibody-drug conjugate (ADC) (144)
Approvals (11571)
Artificial intelligence (284)
Autoimmune disease (29)
Automation (15)
Bankruptcy (238)
Best Places to Work (8692)
BIOSECURE Act (19)
Biosimilars (95)
Biotechnology (49)
Bladder cancer (95)
Brain cancer (31)
Breast cancer (349)
Cancer (2699)
Cardiovascular disease (207)
Career advice (2083)
Career pathing (33)
CAR-T (159)
CDC (35)
Cell therapy (443)
Cervical cancer (21)
Clinical research (52821)
Collaboration (922)
Company closure (2)
Compensation (279)
Complete response letters (29)
COVID-19 (2270)
CRISPR (48)
C-suite (262)
Cystic fibrosis (97)
Data (2890)
Decentralized trials (2)
Denatured (14)
Depression (73)
Diabetes (296)
Diagnostics (5188)
Digital health (20)
Diversity (4)
Diversity, equity & inclusion (31)
Drug discovery (127)
Drug pricing (116)
Drug shortages (27)
Duchenne muscular dystrophy (151)
Earnings (61902)
Editorial (47)
Employer branding (19)
Employer resources (125)
Events (74438)
Executive appointments (557)
FDA (13246)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (719)
Gene editing (115)
Generative AI (26)
Gene therapy (348)
GLP-1 (731)
Government (3669)
Grass and pollen (3)
Guidances (320)
Healthcare (13066)
HIV (34)
Huntington's disease (26)
IgA nephropathy (46)
Immunology and inflammation (165)
Immuno-oncology (15)
Indications (37)
Infectious disease (2431)
Inflammatory bowel disease (133)
Inflation Reduction Act (7)
Influenza (58)
Intellectual property (124)
Interviews (482)
IPO (13657)
IRA (39)
Job creations (2461)
Job search strategy (1741)
Kidney cancer (14)
Labor market (49)
Layoffs (384)
Leadership (26)
Legal (4632)
Liver cancer (73)
Longevity (8)
Lung cancer (377)
Lymphoma (207)
Machine learning (13)
Management (53)
Manufacturing (363)
MASH (87)
Medical device (9707)
Medtech (9712)
Mergers & acquisitions (13665)
Metabolic disorders (787)
Multiple sclerosis (89)
NASH (13)
Neurodegenerative disease (140)
Neuropsychiatric disorders (35)
Neuroscience (1984)
NextGen: Class of 2025 (4132)
Non-profit (2694)
Now hiring (33)
Obesity (398)
Opinion (263)
Ovarian cancer (92)
Pain (107)
Pancreatic cancer (115)
Parkinson's disease (159)
Partnered (17)
Patents (295)
Patient recruitment (158)
Peanut (41)
People (32952)
Pharmaceutical (16)
Pharmacy benefit managers (17)
Phase I (16225)
Phase II (23564)
Phase III (18254)
Pipeline (1998)
Policy (192)
Postmarket research (1646)
Preclinical (6177)
Press Release (56)
Prostate cancer (134)
Psychedelics (29)
Radiopharmaceuticals (207)
Rare diseases (453)
Real estate (3660)
Recruiting (59)
Regulatory (17087)
Reports (37)
Research institute (1730)
Resumes & cover letters (427)
Rett syndrome (8)
RNA editing (8)
RSV (50)
Schizophrenia (92)
Series A (110)
Series B (79)
Service/supplier (5)
Sickle cell disease (57)
Special edition (18)
Spinal muscular atrophy (139)
Sponsored (29)
Startups (2287)
State (1)
Stomach cancer (14)
Supply chain (62)
Tariffs (57)
The Weekly (60)
Vaccines (733)
Venture capital (53)
Weight loss (264)
Women's health (33)
Worklife (19)
Date
Today (116)
Last 7 days (609)
Last 30 days (2090)
Last 365 days (25271)
2025 (15711)
2024 (28470)
2023 (32153)
2022 (40768)
2021 (42822)
2020 (40816)
2019 (32111)
2018 (24262)
2017 (24739)
2016 (22531)
2015 (26581)
2014 (19035)
2013 (22338)
2012 (15802)
2011 (16368)
2010 (14474)
Location
Africa (678)
Alabama (59)
Alaska (5)
Arizona (117)
Arkansas (6)
Asia (29245)
Australia (4892)
California (6360)
Canada (2069)
China (580)
Colorado (262)
Connecticut (275)
Delaware (167)
Europe (65636)
Florida (989)
Georgia (212)
Hawaii (1)
Idaho (29)
Illinois (471)
India (23)
Indiana (312)
Iowa (11)
Japan (205)
Kansas (79)
Kentucky (11)
Louisiana (12)
Maine (67)
Maryland (863)
Massachusetts (4488)
Michigan (195)
Minnesota (337)
Mississippi (2)
Missouri (77)
Montana (24)
Nebraska (14)
Nevada (74)
New Hampshire (55)
New Jersey (1869)
New Mexico (25)
New York (1832)
North Carolina (819)
North Dakota (3)
Northern California (2873)
Ohio (176)
Oklahoma (12)
Oregon (29)
Pennsylvania (1348)
Puerto Rico (16)
Rhode Island (25)
South America (881)
South Carolina (33)
Southern California (2439)
Tennessee (92)
Texas (981)
United States (23076)
Utah (191)
Virginia (157)
Washington D.C. (55)
Washington State (543)
West Virginia (3)
Wisconsin (41)
482,409 Results for "biom up".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Orchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates
August 13, 2025
·
14 min read
Press Releases
Mainz Biomed Receives Swiss Regulatory Approval to Market ColoAlert®
August 14, 2025
·
4 min read
Press Releases
Orchestra BioMed Announces Rollout of FDA-Approved BACKBEAT Global Pivotal Study Protocol Update Significantly Expanding Patient Eligibility
August 11, 2025
·
8 min read
Press Releases
Mainz Biomed Half Year 2025 Update: Accelerating FDA Pathway for NextGen Colorectal Cancer Screening and Expansion with Pancreatic Cancer Screening Acquisition
July 16, 2025
·
7 min read
Press Releases
Harbour BioMed Announces Positive Profit Alert for 2025 Interim Results
July 28, 2025
·
3 min read
Press Releases
Mainz Biomed Announces Pricing of $3.0 Million Follow-On Offering of Ordinary Shares and Warrants
August 5, 2025
·
4 min read
Press Releases
Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
April 28, 2025
·
2 min read
Press Releases
Biocytogen Responds to Harbour BioMed’s Patent Claims: RenNano® is an Independently Developed Platform with Distinct Innovation and Full Legal Standing
June 17, 2025
·
3 min read
Press Releases
Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test
June 25, 2025
·
4 min read
Press Releases
Psyence Biomed Regains Full Compliance with NASDAQ Continued Listing Requirements
June 17, 2025
·
6 min read
1 of 48,241
Next
